Baird Medical Investment Holdings Limited (BDMD) — Capital Reinvestment Ratio
Baird Medical Investment Holdings Limited (BDMD) has a Capital Reinvestment Ratio of 1.97x as of June 2023, meaning it reinvests 2% of its operating cash flow ($642.95K) in capital expenditures ($1.26 Million). See how much free cash does Baird Medical Investment Holdings Limite generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Baird Medical Investment Holdings Limited Capital Reinvestment Ratio (2019–2022)
This chart tracks Baird Medical Investment Holdings Limited's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Baird Medical Investment Holdings Limited (2019–2022)
Year-by-year Capital Reinvestment Ratio for Baird Medical Investment Holdings Limited from 2019 to 2022. For live market cap and broader valuation context, see Baird Medical Investment Holdings Limite market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 12.25x | $485.97K | $5.95 Million | ▲ +4539.9% |
| 2021 | 0.26x | $5.26 Million | $1.39 Million | ▲ +57.4% |
| 2020 | 0.17x | $3.91 Million | $655.35K | ▼ -24.8% |
| 2019 | 0.22x | $4.41 Million | $983.78K | — |